Many African-Americans have a gene that prolongs life after heart failure

About 40 percent of African-Americans have a genetic variant that can protect them after heart failure and prolong their lives, according to research conducted at the School of Medicine and collaborating institutions. The genetic variant has an effect that resembles that of beta blockers, drugs widely prescribed for heart failure. The new study offers a reason why beta blockers don’t appear to benefit some African-Americans.

Readily available treatment could help prevent heart disease in kidney patients

The estimated 19 million Americans living with chronic kidney disease (CKD) face a high risk of death from cardiovascular disease, usually related to high levels of blood phosphate. Now researchers at the School of Medicine have demonstrated that high blood phosphate directly stimulates calcification of blood vessels and that phosphate-binding drugs can decrease vascular calcification.

Washington University in St. Louis and AstraZeneca announce Alzheimer’s research collaboration

The School of Medicine and the pharmaceutical company AstraZeneca (NYSE:AZN) have announced a research collaboration that aims to develop new and improved ways to diagnose and treat Alzheimer’s disease. The major focus of the alliance will be biomarkers, characteristic changes in the brain and spinal fluid that physicians can use to diagnose Alzheimer’s disease and track its response to treatment.

Researchers close in on origins of main ingredient of Alzheimer’s plaques

The ability of brain cells to take in substances from their surface is essential to the production of a key ingredient in Alzheimer’s brain plaques, neuroscientists at the School of Medicine have learned. The researchers used a drug to shut down the intake process, known as endocytosis, in a mouse model of Alzheimer’s disease. The change led to a 70 percent drop in levels of amyloid beta, the protein fragment that clumps together to form Alzheimer’s plaques.

Barch named new director of Conte Center

BarchThe Silvio Conte Center for Neuroscience Research at Washington University has a new director. Deanna Barch, associate professor of psychology in Arts & Sciences, of psychiatry and of radiology, takes over leadership of the center from John Csernansky, the former Gregory B. Couch Professor of Psychiatry, who has become the chairman of psychiatry at Northwestern University.

Technique traces origins of disease genes in mixed races

A team of researchers from Washington University in St. Louis that includes Alan R. Templeton and the Israeli Institute of Technology (Technion) in Haifa has developed a technique to detect the ancestry of disease genes in hybrid, or mixed, human populations. The technique, called expected mutual information (EMI), determines how a set of DNA markers is likely to show the ancestral origin of locations on each chromosome.

Surgeons announce advance in atrial fibrillation surgery

Heart surgeons at the School of Medicine report that by adding a simple 10-20 second step to an operative procedure they achieved a significant improvement in the outcome for the surgical treatment of atrial fibrillation (AF). The surgeons redirected wayward electrical impulses that cause AF by creating precisely placed scars, or ablations, in the heart muscle.
Older Stories